• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PD-1 表达的转录和表观遗传调控。

Transcriptional and epigenetic regulation of PD-1 expression.

机构信息

Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, 250014, China.

Institute of Basic Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, 250014, China.

出版信息

Cell Mol Life Sci. 2021 Apr;78(7):3239-3246. doi: 10.1007/s00018-020-03737-y. Epub 2021 Mar 18.

DOI:10.1007/s00018-020-03737-y
PMID:33738533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11073161/
Abstract

Programmed cell death-1 (PD-1) is a co-inhibitory receptor that plays important roles in regulating T cell immunity and peripheral tolerance. PD-1 signaling prevents T cells from overactivation during acute infections, but it maintains T cell exhaustion during chronic infections. Tumor cells can exploit the PD-1 signaling pathway to evade antitumor immune responses. The PD-1 signaling pathway is also essential for maintaining peripheral tolerance and prevention of autoimmunity. PD-1 expression is strictly and differentially regulated by diverse mechanisms in immune cells. It is activated and repressed by distinct transcription factors in different circumstances. Moreover, epigenetic mechanisms are also involved in regulating PD-1 expression. In this review, we summarize the knowledge of the transcriptional and epigenetic regulation of PD-1 expression during different immune responses.

摘要

程序性细胞死亡蛋白-1(PD-1)是一种共抑制受体,在调节 T 细胞免疫和外周耐受方面发挥着重要作用。PD-1 信号在急性感染期间阻止 T 细胞过度激活,但在慢性感染期间维持 T 细胞耗竭。肿瘤细胞可以利用 PD-1 信号通路来逃避抗肿瘤免疫反应。PD-1 信号通路对于维持外周耐受和预防自身免疫也很重要。PD-1 的表达在免疫细胞中受到多种机制的严格和差异调控。它在不同情况下被不同的转录因子激活和抑制。此外,表观遗传机制也参与调节 PD-1 的表达。在这篇综述中,我们总结了不同免疫反应中 PD-1 表达的转录和表观遗传调控的知识。

相似文献

1
Transcriptional and epigenetic regulation of PD-1 expression.PD-1 表达的转录和表观遗传调控。
Cell Mol Life Sci. 2021 Apr;78(7):3239-3246. doi: 10.1007/s00018-020-03737-y. Epub 2021 Mar 18.
2
Genetic and Epigenetic Regulation of PD-1 Expression.程序性死亡受体1(PD-1)表达的遗传与表观遗传调控
J Immunol. 2016 Mar 15;196(6):2431-7. doi: 10.4049/jimmunol.1502643.
3
Regulation of PD-1 in T cells for cancer immunotherapy.T 细胞中 PD-1 的调控用于癌症免疫治疗。
Eur J Pharmacol. 2020 Aug 15;881:173240. doi: 10.1016/j.ejphar.2020.173240. Epub 2020 Jun 1.
4
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.新型自身免疫性胰腺炎小鼠模型中PD-1和FoxP3在维持免疫耐受中的非重叠作用
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8490-5. doi: 10.1073/pnas.1608873113. Epub 2016 Jul 7.
5
Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells.糖皮质激素通过上调 T 细胞程序性细胞死亡 1 的表达增强其抑制能力。
J Biol Chem. 2019 Dec 27;294(52):19896-19906. doi: 10.1074/jbc.RA119.010379. Epub 2019 Nov 13.
6
PD-1 and autoimmunity.程序性死亡受体1(PD-1)与自身免疫
Crit Rev Immunol. 2011;31(4):265-95. doi: 10.1615/critrevimmunol.v31.i4.10.
7
Programmed death-1 pathway in cancer and autoimmunity.程序性细胞死亡蛋白 1 通路与癌症和自身免疫。
Clin Immunol. 2014 Jul;153(1):145-52. doi: 10.1016/j.clim.2014.04.010. Epub 2014 Apr 26.
8
Biochemical signaling of PD-1 on T cells and its functional implications.T细胞上PD-1的生化信号传导及其功能意义。
Cancer J. 2014 Jul-Aug;20(4):265-71. doi: 10.1097/PPO.0000000000000059.
9
Programmed cell death 1-directed immunotherapy for enhancing T-cell function.程序性细胞死亡蛋白1导向的免疫疗法以增强T细胞功能。
Cold Spring Harb Symp Quant Biol. 2013;78:239-47. doi: 10.1101/sqb.2013.78.019869.
10
Exhausted T cells and epigenetic status.耗竭的 T 细胞和表观遗传状态。
Cancer Biol Med. 2020 Nov 15;17(4):923-936. doi: 10.20892/j.issn.2095-3941.2020.0338. Epub 2020 Dec 15.

引用本文的文献

1
Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential.肝细胞癌治疗中靶向免疫检查点:迈向具有治愈潜力的联合策略
Exp Hematol Oncol. 2025 May 2;14(1):65. doi: 10.1186/s40164-025-00636-5.
2
Programmed cell death protein 1 in cancer cells.癌细胞中的程序性细胞死亡蛋白1
Cell Commun Signal. 2025 Apr 16;23(1):185. doi: 10.1186/s12964-025-02155-6.
3
New insight in immunotherapy and combine therapy in colorectal cancer.结直肠癌免疫治疗与联合治疗的新见解。
Front Cell Dev Biol. 2025 Jan 7;12:1453630. doi: 10.3389/fcell.2024.1453630. eCollection 2024.
4
The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy.慢性粒细胞白血病(CML)的经验有助于阐明天然T细胞作为效应细胞在控制残留癌细胞中的作用以及作为癌症治疗潜在靶点的作用。
Front Immunol. 2024 Nov 15;15:1473139. doi: 10.3389/fimmu.2024.1473139. eCollection 2024.
5
Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms.噬血细胞性淋巴组织细胞增生症:当前的治疗进展、新兴的靶向治疗和潜在机制。
J Hematol Oncol. 2024 Nov 7;17(1):106. doi: 10.1186/s13045-024-01621-x.
6
PD-L2 of tumor-derived exosomes mediates the immune escape of cancer cells via the impaired T cell function.肿瘤来源的外泌体中的 PD-L2 通过损伤 T 细胞功能介导癌细胞的免疫逃逸。
Cell Death Dis. 2024 Nov 7;15(11):800. doi: 10.1038/s41419-024-07191-7.
7
Myeloid gasdermin D drives early-stage T cell immunity and peripheral inflammation in a mouse model of Alzheimer's disease.髓系细胞焦亡因子 D 驱动阿尔茨海默病小鼠模型早期 T 细胞免疫和外周炎症反应。
J Neuroinflammation. 2024 Oct 19;21(1):266. doi: 10.1186/s12974-024-03255-9.
8
The Role of the Large T Antigen in the Molecular Pathogenesis of Merkel Cell Carcinoma.大 T 抗原在 Merkel 细胞癌分子发病机制中的作用。
Genes (Basel). 2024 Aug 27;15(9):1127. doi: 10.3390/genes15091127.
9
Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer.肿瘤微环境的表观遗传调控:推动胰腺癌发展的主导力量。
Pancreatology. 2024 Sep;24(6):878-886. doi: 10.1016/j.pan.2024.07.005. Epub 2024 Jul 15.
10
Exploring the Role of PD-1 in the Autoimmune Response: Insights into Its Implication in Systemic Lupus Erythematosus.探索 PD-1 在自身免疫反应中的作用:对系统性红斑狼疮中其作用的深入了解。
Int J Mol Sci. 2024 Jul 15;25(14):7726. doi: 10.3390/ijms25147726.

本文引用的文献

1
The Role of PD-1 in Acute and Chronic Infection.PD-1 在急性和慢性感染中的作用。
Front Immunol. 2020 Mar 24;11:487. doi: 10.3389/fimmu.2020.00487. eCollection 2020.
2
PD-1 Expression during Acute Infection Is Repressed through an LSD1-Blimp-1 Axis.PD-1 表达在急性感染期间受到 LSD1-Blimp-1 轴的抑制。
J Immunol. 2020 Jan 15;204(2):449-458. doi: 10.4049/jimmunol.1900601. Epub 2019 Dec 6.
3
Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway.癌症免疫疗法中针对 PD-1 信号通路的开发与临床应用。
J Biomed Sci. 2019 Dec 5;26(1):96. doi: 10.1186/s12929-019-0588-8.
4
Immune checkpoint inhibitors: The linchpins of modern immunotherapy.免疫检查点抑制剂:现代免疫疗法的关键。
Immunol Rev. 2019 Jul;290(1):6-23. doi: 10.1111/imr.12766.
5
Dynamic DNA methylation: In the right place at the right time.动态 DNA 甲基化:在适当的时间出现在适当的位置。
Science. 2018 Sep 28;361(6409):1336-1340. doi: 10.1126/science.aat6806.
6
Cancer immunotherapy using checkpoint blockade.使用免疫检查点阻断的癌症免疫疗法。
Science. 2018 Mar 23;359(6382):1350-1355. doi: 10.1126/science.aar4060. Epub 2018 Mar 22.
7
Inhibitors of the PD-1 Pathway in Tumor Therapy.肿瘤治疗中的 PD-1 通路抑制剂。
J Immunol. 2018 Jan 15;200(2):375-383. doi: 10.4049/jimmunol.1701044.
8
PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.程序性死亡受体1(PD-1)是T细胞淋巴瘤发生发展的单倍不足抑制因子。
Nature. 2017 Dec 7;552(7683):121-125. doi: 10.1038/nature24649. Epub 2017 Nov 15.
9
The diverse functions of the PD1 inhibitory pathway.PD1 抑制通路的多种功能。
Nat Rev Immunol. 2018 Mar;18(3):153-167. doi: 10.1038/nri.2017.108. Epub 2017 Nov 13.
10
Cancer immunotherapies targeting the PD-1 signaling pathway.靶向PD-1信号通路的癌症免疫疗法。
J Biomed Sci. 2017 Apr 4;24(1):26. doi: 10.1186/s12929-017-0329-9.